Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

RELMADA THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable

RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Accounts Payable of $840.25 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06

  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$922.21K, a 1051.70% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.76M.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $115.84K, a 93.51% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $91.19K.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$2.56M, a 510.15% decline from fiscal 2024.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $624.55K.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$1.76M, a 517.05% decline from fiscal 2022.
  • RELMADA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $421.04K, a 85.21% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 monthIncrease (Decrease) in Accounts Payable 21 monthIncrease (Decrease) in Accounts Payable 24 monthIncrease (Decrease) in Accounts Payable 27 monthIncrease (Decrease) in Accounts Payable 30 monthIncrease (Decrease) in Accounts Payable 33 monthIncrease (Decrease) in Accounts Payable 115 monthIncrease (Decrease) in Accounts Payable 118 month
2026-06-30-$922.21K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$840.25K
10-Q · filed 2026-08-06
$956.09K
derived: sum of 3 quarters · filed 2026-08-06
$1.05M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.76M
10-Q · filed 2026-05-12
$1.88M
derived: sum of 2 quarters · filed 2026-05-12
$1.97M
derived: sum of 3 quarters · filed 2026-05-12
$2.07M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$115.84K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$207.03K
derived: sum of 2 quarters · filed 2026-03-19
$303.93K
derived: sum of 3 quarters · filed 2026-08-06
-$2.56M
10-K · filed 2026-03-19
2025-09-30$91.19K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$188.09K
derived: sum of 2 quarters · filed 2026-08-06
-$2.68M
10-Q · filed 2025-11-13
-$892.44K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$96.90K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$2.77M
10-Q · filed 2026-08-06
-$983.63K
derived: sum of 3 quarters · filed 2026-08-06
-$2.81M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$2.87M
10-Q · filed 2026-05-12
-$1.08M
derived: sum of 2 quarters · filed 2026-05-12
-$2.91M
derived: sum of 3 quarters · filed 2026-05-12
-$3.92M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$1.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$44.01K
derived: sum of 2 quarters · filed 2026-03-19
-$1.06M
derived: sum of 3 quarters · filed 2026-03-19
$624.55K
10-K · filed 2026-03-19
2024-09-30-$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$2.84M
derived: sum of 2 quarters · filed 2025-11-13
-$1.16M
10-Q · filed 2025-11-13
-$511.21K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$668.56K
10-Q · filed 2025-08-07
$1.32M
derived: sum of 3 quarters · filed 2025-08-07
-$679.05K
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$1.68M
10-Q · filed 2025-05-12
$2.33M
derived: sum of 2 quarters · filed 2025-05-12
$335.49K
derived: sum of 3 quarters · filed 2025-05-12
$767.14K
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$649.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$1.35M
derived: sum of 2 quarters · filed 2025-03-27
-$915.96K
derived: sum of 3 quarters · filed 2025-03-27
-$1.76M
10-K · filed 2025-03-27
2023-09-30-$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$1.57M
derived: sum of 2 quarters · filed 2024-11-07
-$2.41M
10-Q · filed 2024-11-07
-$1.22M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$431.65K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$408.32K
10-Q · filed 2024-08-07
$779.38K
derived: sum of 3 quarters · filed 2024-08-07
-$2.69M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$839.97K
10-Q · filed 2024-05-08
$347.73K
derived: sum of 2 quarters · filed 2024-05-08
-$3.12M
derived: sum of 3 quarters · filed 2024-05-08
$103.42K
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$2.28M
derived: sum of 2 quarters · filed 2024-03-19
$943.39K
derived: sum of 3 quarters · filed 2024-03-19
$421.04K
10-K · filed 2024-03-19
2022-09-30-$3.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$244.31K
derived: sum of 2 quarters · filed 2023-11-08
-$766.66K
10-Q · filed 2023-11-08
-$2.28M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$3.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$2.70M
10-Q · filed 2023-08-08
$1.18M
derived: sum of 3 quarters · filed 2023-08-08
$3.44M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$522.35K
10-Q · filed 2023-05-11
-$2.04M
derived: sum of 2 quarters · filed 2023-05-11
$214.23K
derived: sum of 3 quarters · filed 2023-05-11
$2.59M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$736.58K
derived: sum of 2 quarters · filed 2023-03-23
$3.11M
derived: sum of 3 quarters · filed 2023-03-23
$2.85M
10-K · filed 2023-03-23
2021-09-30$2.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$4.63M
derived: sum of 2 quarters · filed 2022-11-10
$4.36M
10-Q · filed 2022-11-10
$11.98M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$2.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$2.11M
10-Q · filed 2022-08-11
$9.73M
derived: sum of 3 quarters · filed 2022-08-11
$9.49M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$263.68K
10-Q · filed 2022-05-05
$7.35M
derived: sum of 2 quarters · filed 2022-05-05
$7.12M
derived: sum of 3 quarters · filed 2022-05-05
$6.98M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$7.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$7.38M
derived: sum of 2 quarters · filed 2022-03-25
$7.24M
derived: sum of 3 quarters · filed 2022-03-25
$7.82M
10-K · filed 2022-03-25
2020-09-30-$236.54K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$374.18K
derived: sum of 2 quarters · filed 2021-11-12
$205.97K
10-Q · filed 2021-11-12
-$537.91K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$137.65K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$442.51K
10-Q · filed 2021-08-10
-$301.38K
derived: sum of 3 quarters · filed 2021-08-10
$40.81K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$580.15K
10-Q · filed 2021-05-12
-$163.73K
derived: sum of 2 quarters · filed 2021-05-12
$178.46K
derived: sum of 3 quarters · filed 2021-05-12
$22.70K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$743.88K
derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24
-$401.70K
10-K · filed 2021-03-24
-$557.45K
derived: sum of 3 quarters · filed 2021-03-24
$163.77K
10-K · filed 2021-03-24
2019-09-30$342.19K
10-Q · filed 2019-11-13
$186.44K
derived: sum of 2 quarters · filed 2020-08-12
$907.66K
10-Q · filed 2020-11-12
$247.19K
derived: sum of 4 quarters · filed 2020-08-12
2019-06-30-$155.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$565.47K
10-Q · filed 2020-08-12
-$95.00K
derived: sum of 3 quarters · filed 2020-08-12
$158.92K
10-K · filed 2021-03-24
2019-03-31$721.22K
10-Q · filed 2020-05-15
$60.75K
derived: sum of 2 quarters · filed 2020-05-15
$314.67K
10-Q · filed 2019-05-15
-$11.47K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$660.47K
derived: 10-KT 6 month − 10-Q 3 month · filed 2020-03-26
-$406.55K
10-KT · filed 2020-03-26
-$732.69K
derived: sum of 3 quarters · filed 2020-03-26
$72.84K
derived: sum of 4 quarters · filed 2020-03-26
2018-09-30$253.92K
10-Q · filed 2019-11-13
-$72.22K
derived: sum of 2 quarters · filed 2020-03-26
$733.30K
derived: sum of 3 quarters · filed 2020-03-26
$643.82K
derived: sum of 4 quarters · filed 2020-03-26
2018-06-30-$326.14K
derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26
$479.39K
derived: sum of 2 quarters · filed 2020-03-26
$389.90K
derived: sum of 3 quarters · filed 2020-03-26
$157.39K
10-KT · filed 2020-03-26
2018-03-31$805.53K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15
$716.04K
derived: sum of 2 quarters · filed 2019-05-15
$483.53K
10-Q · filed 2019-05-15
$677.66K
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$89.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13
-$322.00K
10-Q · filed 2019-02-13
-$127.87K
derived: sum of 3 quarters · filed 2019-02-13
-$99.67K
derived: sum of 4 quarters · filed 2019-02-13
2017-09-30-$232.51K
10-Q · filed 2018-11-13
-$38.38K
derived: sum of 2 quarters · filed 2018-11-13
-$10.19K
derived: sum of 3 quarters · filed 2018-11-13
-$374.67K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$194.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28
$222.32K
derived: sum of 2 quarters · filed 2018-09-28
-$142.16K
derived: sum of 3 quarters · filed 2018-09-28
-$730.15K
10-K · filed 2018-09-28
2017-03-31$28.20K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14
-$336.29K
derived: sum of 2 quarters · filed 2018-05-14
-$924.28K
10-Q · filed 2018-05-14
-$408.73K
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$364.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12
-$952.48K
10-Q · filed 2018-02-12
-$436.93K
derived: sum of 3 quarters · filed 2018-02-12
-$1.34M
derived: sum of 4 quarters · filed 2018-02-12
2016-09-30-$587.99K
10-Q · filed 2017-11-14
-$72.44K
derived: sum of 2 quarters · filed 2017-11-14
-$974.37K
derived: sum of 3 quarters · filed 2017-11-14
-$478.28K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$515.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28
-$386.38K
derived: sum of 2 quarters · filed 2017-09-28
$109.71K
derived: sum of 3 quarters · filed 2017-09-28
$424.43K
10-K · filed 2017-09-28
2016-03-31-$901.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15
-$405.84K
derived: sum of 2 quarters · filed 2017-05-15
-$91.13K
10-Q · filed 2017-05-15
$353.79K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$496.09K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10
$810.80K
10-Q · filed 2017-02-10
$1.26M
derived: sum of 3 quarters · filed 2017-02-10
$676.13K
derived: sum of 4 quarters · filed 2017-02-10
2015-09-30$314.71K
10-Q · filed 2016-11-10
$759.63K
derived: sum of 2 quarters · filed 2016-11-10
$180.04K
derived: sum of 3 quarters · filed 2016-11-10
$525.26K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$444.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09
-$134.67K
derived: sum of 2 quarters · filed 2016-09-09
$210.55K
derived: sum of 3 quarters · filed 2016-09-09
$89.19K
10-K · filed 2016-09-09
2015-03-31-$579.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09
-$234.36K
derived: sum of 2 quarters · filed 2016-05-09
-$355.73K
10-Q · filed 2016-05-09
$263.28K
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31$345.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05
$223.86K
10-Q · filed 2016-02-05
$842.86K
derived: sum of 3 quarters · filed 2016-02-05
$789.63K
derived: sum of 4 quarters · filed 2016-02-05
2014-09-30-$121.36K
10-Q · filed 2015-11-06
$497.64K
derived: sum of 2 quarters · filed 2015-11-06
$444.41K
derived: sum of 3 quarters · filed 2015-11-06
2014-06-30$619.01K
derived: 10-K 6 month − 8-K 3 month · filed 2015-09-11
$565.78K
10-K · filed 2015-09-11
2014-03-31-$53.23K
8-K · filed 2014-05-27
$24.98K
10-Q · filed 2015-05-15
$127.09K
8-K · filed 2014-05-27
2014-02-28$824.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15
$7.49K
10-Q · filed 2014-04-15
$41.16K
10-Q · filed 2014-04-15
2013-12-31$77.16K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-13
$78.20K
10-Q · filed 2015-02-13
-$57.10K
10-K · filed 2015-09-11
$180.32K
8-K · filed 2014-05-27
2013-11-30$6.67K
10-Q · filed 2014-01-13
$40.33K
10-Q · filed 2014-01-13
2013-09-30$1.05K
10-Q · filed 2014-11-07
2013-08-31$1.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16
$15.40K
derived: sum of 2 quarters · filed 2013-12-16
$20.40K
10-K · filed 2013-12-16
$33.50K
10-K · filed 2013-12-16
2013-05-31$13.75K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12
$18.75K
10-Q · filed 2013-07-12
$25.75K
10-Q · filed 2013-07-12
2013-03-31-$30.00
8-K · filed 2014-05-27
2013-02-28-$661.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15
$5.01K
10-Q · filed 2014-04-15
$11.94K
derived: sum of 3 quarters · filed 2014-04-15
$11.76K
derived: sum of 4 quarters · filed 2014-04-15
$12.00K
10-Q · filed 2013-05-03
2012-12-31$32.30K
10-KT · filed 2014-09-09
2012-11-30$5.67K
10-Q · filed 2014-01-13
$12.60K
derived: sum of 2 quarters · filed 2014-01-13
$12.42K
derived: sum of 3 quarters · filed 2014-01-13
2012-08-31$6.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16
$6.75K
derived: sum of 2 quarters · filed 2013-12-16
$7.00K
10-K · filed 2013-12-16
2012-05-31-$183.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12
$59.00
10-Q · filed 2013-07-12
2012-02-29$242.00
10-Q · filed 2013-05-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63